Prudential Financial’s Synergy Pharmaceuticals, Inc Common Stock SGYP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q1
Sell
-18,340
Closed -$2K 2500
2018
Q4
$2K Sell
18,340
-680
-4% -$446 ﹤0.01% 2375
2018
Q3
$32K Hold
19,020
﹤0.01% 2408
2018
Q2
$33K Buy
19,020
+520
+3% +$899 ﹤0.01% 2415
2018
Q1
$34K Hold
18,500
﹤0.01% 2327
2017
Q4
$41K Buy
18,500
+970
+6% +$2.41K ﹤0.01% 2314
2017
Q3
$51K Sell
17,530
-1,100
-6% -$3.75K ﹤0.01% 2315
2017
Q2
$83K Buy
18,630
+2,440
+15% +$10.1K ﹤0.01% 2305
2017
Q1
$75K Buy
16,190
+3,560
+28% +$20.6K ﹤0.01% 2303
2016
Q4
$77K Sell
12,630
-100
-0.8% -$523 ﹤0.01% 2307
2016
Q3
$70K Buy
12,730
+1,230
+11% +$5.76K ﹤0.01% 2291
2016
Q2
$44K Buy
+11,500
New +$39K ﹤0.01% 2272
2014
Q3
Sell
-16,600
Closed -$68K 2361
2014
Q2
$68K Buy
+16,600
New +$70.5K ﹤0.01% 2366

Other funds holding SGYP

Prudential Financial's SGYP Position: Q1 2019 in Review

Prudential Financial sold out of Synergy Pharmaceuticals, Inc Common Stock (SGYP) in Q1 2019, closing a stake of 18,340 shares — an estimated $2K sold.

Prudential Financial first reported a position in SGYP in Q2 2014 and held it in 12 quarters. The position peaked at $83K in Q2 2017. 12 funds tracked by Wall St. Rank hold SGYP as of Q1 2019.

  • Prudential Financial reported no remaining Synergy Pharmaceuticals, Inc Common Stock position as of Q1 2019 after selling out during the quarter.
  • Prudential Financial sold 18,340 Synergy Pharmaceuticals, Inc Common Stock shares in Q1 2019, an estimated $2K.
  • Prudential Financial first reported a position in Synergy Pharmaceuticals, Inc Common Stock in Q2 2014 and held it in 12 quarters.
  • Prudential Financial's Synergy Pharmaceuticals, Inc Common Stock position peaked at $83K in Q2 2017.
  • 12 funds tracked by Wall St. Rank held Synergy Pharmaceuticals, Inc Common Stock as of Q1 2019.

Based on Prudential Financial's 13F filing for Q1 2019, filed 15 May 2019.